Armata Pharmaceuticals, Inc. (ARMP)
5.84
+0.32
(+5.80%)
USD |
NYAM |
Sep 04, 16:00
5.83
-0.01
(-0.17%)
After-Hours: 20:00
Armata Pharmaceuticals Shareholders Equity (Quarterly) : -231.17M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -231.17M |
| March 31, 2026 | -311.59M |
| December 31, 2025 | -218.60M |
| September 30, 2025 | -95.59M |
| June 30, 2025 | -69.50M |
| March 31, 2025 | -53.78M |
| December 31, 2024 | -48.02M |
| September 30, 2024 | -50.97M |
| June 30, 2024 | -46.10M |
| March 31, 2024 | -56.51M |
| December 31, 2023 | -32.06M |
| September 30, 2023 | -12.39M |
| June 30, 2023 | 19.14M |
| March 31, 2023 | 22.45M |
| December 31, 2022 | 36.08M |
| September 30, 2022 | 45.58M |
| June 30, 2022 | 53.29M |
| March 31, 2022 | 61.54M |
| December 31, 2021 | 25.40M |
| September 30, 2021 | 23.76M |
| June 30, 2021 | 28.62M |
| March 31, 2021 | 34.01M |
| December 31, 2020 | 18.86M |
| September 30, 2020 | 24.62M |
| June 30, 2020 | 29.64M |
| Date | Value |
|---|---|
| March 31, 2020 | 33.48M |
| December 31, 2019 | 14.59M |
| September 30, 2019 | 18.13M |
| June 30, 2019 | 22.63M |
| March 31, 2019 | 4.961M |
| December 31, 2018 | 7.694M |
| September 30, 2018 | 6.853M |
| June 30, 2018 | 8.339M |
| March 31, 2018 | 11.29M |
| December 31, 2017 | 7.731M |
| September 30, 2017 | 9.757M |
| June 30, 2017 | 9.861M |
| March 31, 2017 | 6.648M |
| December 31, 2016 | 9.723M |
| September 30, 2016 | 18.23M |
| June 30, 2016 | 21.48M |
| March 31, 2016 | 22.51M |
| December 31, 2015 | 24.60M |
| September 30, 2015 | 26.60M |
| June 30, 2015 | 17.11M |
| March 31, 2015 | -0.748M |
| December 31, 2014 | 5.427M |
| September 30, 2014 | 6.028M |
| June 30, 2014 | -16.59M |
| March 31, 2014 | -27.17M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 89.95M |
| Total Liabilities (Quarterly) | 321.12M |
| Debt to Equity Ratio | -1.358 |
| Current Ratio | 0.1085 |
| Net Debt Paydown Yield | -14.90% |